
All pregnant patients should be screened for atypical antibodies. Anti-D immunoglobulin should be administered to Rh-negative patients after an abortion, ectopic pregnancy, and delivery of an Rh-negative infant to prevent the occurrence of immunization. The management of immunized patients is discussed.
Erythroblastosis, Fetal, Rh-Hr Blood-Group System, Isoantibodies, Pregnancy, Blood Group Incompatibility, Blood Transfusion, Intrauterine, Humans, Female, ABO Blood-Group System
Erythroblastosis, Fetal, Rh-Hr Blood-Group System, Isoantibodies, Pregnancy, Blood Group Incompatibility, Blood Transfusion, Intrauterine, Humans, Female, ABO Blood-Group System
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
